Moody's Sees Potential Pfizer/Allergan Deal as Credit-Positive Development (PFE) (AGN)

Go back to Moody's Sees Potential Pfizer/Allergan Deal as Credit-Positive Development (PFE) (AGN)

Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital

October 29, 2015 10:40 AM EDT

The potential Allergan (NYSE: AGN)/Pfizer (NYSE: PFE) deal would bring attractive strategic and financial aspects and focus will shift to the likelihood of actually getting done if the price is right and management structure can be agreed... More

Pfizer (PFE) Confirms Discussions with Allergan (AGN)

October 29, 2015 10:10 AM EDT

Pfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More

Allergan (AGN) Affirms Talks with Pfizer (PFE)

October 29, 2015 9:31 AM EDT

Allergan (NYSE: AGN) confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions... More

Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ

October 28, 2015 9:34 PM EDT

Pfizer (NYSE: PFE) and Allergan (NYSE: AGN) are considering a merger the Wall Street Journal reported late Wednesday, citing people familiar with the matter.

Pfizer has approached Allergan about a... More